| |
| |
|
| Insider
Information: |
Altomari Alfred |
| Relationship: |
Director |
| City: |
Princeton |
| State: |
NJ |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
279,225 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$3,884,180 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
279,225 |
|
|
| Total
Value |
$3,884,180 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
6
|
0
|
|
Stock
price went up :
|
1
|
0
|
| Stock
price went down : |
5
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
 -62.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Insmed Inc |
INSM |
Director |
2024-05-13 |
69,495 |
2013-08-02 |
0 |
Premium* |
|
|
Agile Therapeutics Inc |
AGRX |
Chief Executive Office... |
2023-06-28 |
47,749 |
|
0 |
Premium* |
|
|
Societal CDMO, Inc |
SCTL |
Director |
2019-12-05 |
44,196 |
2016-12-15 |
0 |
Premium* |
|
|
Baudax Bio, Inc. |
BXRX |
Director |
2021-04-07 |
117,785 |
2019-12-05 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| INSM |
Insmed Inc |
Director |
– • – |
2020-12-07 |
4 |
AS |
$39.57 |
$791,400 |
D/D |
(20,000) |
20,938 |
0 |
% |
|
| INSM |
Insmed Inc |
Director |
– • – |
2019-02-26 |
4 |
AS |
$30.00 |
$165,000 |
D/D |
(5,500) |
25,942 |
0 |
- |
|
| INSM |
Insmed Inc |
Director |
– • – |
2019-02-15 |
4 |
AS |
$27.50 |
$151,250 |
D/D |
(5,500) |
31,442 |
0 |
- |
|
| INSM |
Insmed Inc |
Director |
– • – |
2019-02-05 |
4 |
AS |
$25.00 |
$137,500 |
D/D |
(5,500) |
36,942 |
0 |
- |
|
| INSM |
Insmed Inc |
Director |
– • – |
2019-01-10 |
4 |
AS |
$22.50 |
$123,750 |
D/D |
(5,500) |
42,442 |
0 |
- |
|
| AGRX |
Agile Therapeutics Inc |
Chief Executive Officer |
• • – |
2015-06-02 |
4 |
B |
$8.73 |
$21,825 |
D/D |
2,500 |
78,254 |
2.81 |
- |
|
| SCTL |
Societal CDMO, Inc |
Director |
– • – |
2016-12-15 |
4 |
B |
$6.55 |
$9,825 |
D/D |
1,500 |
1,500 |
2.39 |
- |
|
| AGRX |
Agile Therapeutics Inc |
Chairman and Chief Executive O |
• • – |
2017-05-11 |
4 |
B |
$3.51 |
$35,100 |
D/D |
10,000 |
151,587 |
2.81 |
- |
|
| AGRX |
Agile Therapeutics Inc |
Chairman & Chief Executive Off |
• • – |
2017-08-25 |
4 |
B |
$3.34 |
$33,400 |
D/D |
10,000 |
161,587 |
2.81 |
- |
|
| AGRX |
Agile Therapeutics Inc |
Chief Executive Officer |
• • – |
2020-02-27 |
4 |
B |
$2.71 |
$27,100 |
D/D |
10,000 |
311,611 |
2.81 |
- |
|
| BXRX |
Baudax Bio, Inc. |
Director |
– • – |
2020-03-26 |
4 |
B |
$2.34 |
$11,700 |
D/D |
5,000 |
33,382 |
2.39 |
- |
|
| AGRX |
Agile Therapeutics Inc |
Chief Executive Officer |
• • – |
2021-03-23 |
4 |
B |
$2.00 |
$25,030 |
D/D |
12,500 |
468,710 |
2.81 |
% |
|
| AGRX |
Agile Therapeutics Inc |
Chief Executive Officer |
• • – |
2014-12-18 |
4 |
OE |
$1.76 |
$52,800 |
D/D |
30,000 |
58,254 |
0 |
- |
|
| AGRX |
Agile Therapeutics Inc |
Chief Executive Officer |
• • – |
2015-03-11 |
4 |
OE |
$1.76 |
$30,800 |
D/D |
17,500 |
75,754 |
0 |
- |
|
| AGRX |
Agile Therapeutics Inc |
Chairman & Chief Exec Officer |
• • – |
2017-04-11 |
4 |
OE |
$1.76 |
$52,800 |
D/D |
30,000 |
141,587 |
0 |
- |
|
| AGRX |
Agile Therapeutics Inc |
Chief Executive Officer |
• • – |
2020-06-22 |
4 |
OE |
$1.76 |
$88,000 |
D/D |
50,000 |
361,611 |
0 |
- |
|
| AGRX |
Agile Therapeutics Inc |
Chief Executive Officer |
• • – |
2020-08-20 |
4 |
OE |
$1.76 |
$166,494 |
D/D |
94,599 |
456,210 |
0 |
- |
|
| AGRX |
Agile Therapeutics Inc |
Chief Executive Officer |
• • – |
2021-05-18 |
4 |
B |
$1.61 |
$32,200 |
D/D |
20,000 |
488,710 |
2.81 |
% |
|
| AGRX |
Agile Therapeutics Inc |
Chief Executive Officer |
• • – |
2019-03-25 |
4 |
B |
$1.54 |
$38,500 |
D/D |
25,000 |
238,568 |
2.81 |
- |
|
| AGRX |
Agile Therapeutics Inc |
Chief Executive Officer |
• • – |
2019-06-10 |
4 |
B |
$1.27 |
$25,400 |
D/D |
20,000 |
258,568 |
2.81 |
- |
|
| AGRX |
Agile Therapeutics Inc |
Chief Executive Officer |
• • – |
2021-07-29 |
4 |
B |
$1.26 |
$33,096 |
D/D |
26,200 |
514,910 |
2.81 |
% |
|
| BXRX |
Baudax Bio, Inc. |
Director |
– • – |
2020-11-23 |
4 |
B |
$1.06 |
$5,300 |
D/D |
5,000 |
61,333 |
2.39 |
- |
|
| AGRX |
Agile Therapeutics Inc |
Chief Executive Officer |
• • – |
2020-02-27 |
4 |
OE |
$0.71 |
$11,744 |
D/D |
16,541 |
301,611 |
0 |
- |
|
| AGRX |
Agile Therapeutics Inc |
Chief Executive Officer |
• • – |
2022-08-26 |
4 |
B |
$0.45 |
$22,500 |
D/D |
50,000 |
64,343 |
2.81 |
% |
|
| INSM |
Insmed Inc |
Director |
– • – |
2013-08-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,327 |
4,327 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
